Immune Cells as Trojan Horses for Cancer Nanotherapy
Cristina Hermosillo‐Abundis, Jessica Andrea Flood-Garibay, Vanesa Ayala‐Nunez, M.A. Mendéz-Rojas
Universidad de las Américas Puebla Swiss Federal Laboratories for Materials Science and Technology
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
High Resolution Image Download MS PowerPoint Slide Nanotechnology is a promising strategy in the fight against cancer by leveraging the unique properties of nanomaterials for targeted drug delivery. A significant challenge in this domain is overcoming biological barriers and ensuring precise delivery to tumor sites. Immune cells, inherently adept at navigating the body’s defense systems and homing to tumor sites, present an excellent solution as Trojan horses for cancer nanotherapy. This review explores the utilization of immune cells as carriers or mediators of nanoparticle-based therapeutics. The Trojan horse strategy is presented in the context of nanomedicine and cancer, followed by a discussion of its advantages. Next, the diversity of nanoparticle systems that have shown positive therapeutic outcomes in preclinical studies is explored. The challenges of using immune cells as Trojan horses, such as nanoparticle loading and manipulation, are analyzed. Finally, strategies for fine-tuning nanoparticles to design an effective Trojan horse approach are suggested. By synthesizing current research findings, this review underscores the potential of nanotechnology in combination with immune cells for innovative and effective cancer treatments.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
材料 / 化学Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses
参考文献 121
此处列出前 3 条
引用本文 7
按被引量排序,此处列出前 3 条